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 Abstract - The present study was aimed to assess 
the changes in skin microvascular blood flow (SBF) 
in newly diagnosed hyperglycemic obese subjects, 
administered with hypocaloric diet. Adult patients 
were recruited and divided in three groups: NW 
group (n=54), NG (n=54) and HG (n=54) groups 
were constituted by normal weight, normoglycemic 
and hyperglycemic obese subjects, respectively. SBF 
was measured by laser Doppler perfusion monitoring 
technique and oscillations in blood flow were 
analyzed by spectral methods under baseline 
conditions, at 3 and 6 months of dietary treatment. 
Under resting conditions, SBF was lower in HG 
group than in NG and NW ones. Moreover, all 
subjects showed blood flow oscillations with several 
frequency components. In particular, hyperglycemic 
obese patients revealed lower spectral density in 
myogenic-related component than normoglycemic 
obese and normal weight ones. Moreover, post-
occlusive reactive hyperemia (PORH) was impaired 
in hyperglycemic obese compared to normoglycemic 
and normal weigh subjects. After hypocaloric diet, in 
hyperglycemic obese patients there was an 
improvement in  SBF accompanied by recovery in  
myogenic-related oscillations and arteriolar 
responses during PORH. In conclusion, 
hyperglycemia markedly affected peripheral 
microvascular function; hypocaloric diet ameliorated 
tissue blood flow.  
 
Keywords: obesity, hyperglycemia, hypocaloric diet, 
microvascular blood flow, laser Doppler perfusion 
monitoring. 
 
I.  INTRODUCTION 
 
 Hyperglycemia is known as the first sign of 
glucose metabolic impairment, affecting several organ 
functions [1]. Hyperglycemia, indeed, contributes to 
micro-angiopathy, causing target-organ damage such as 
retinopathy and nephropathy in diabetes [2-5]. Therefore, 
it is important to determine the early dysfunctions, such as 
microvascular impairment, leading to severe 
complications. 
Laser Doppler perfusion monitoring (LDPM) is a 
non-invasive and real-time diagnostic method to evaluate 
microvascular function [6-8]. This technique permits to 
study human skin blood flow under several 
pathophysiological conditions [9-13]. The skin represents, 
indeed, an easily accessible organ and the skin 
microvascular dysfunctions have been suggested to be 
related to microvascular changes in different organs [14]. 
Moreover, spectral analysis of LDPM signals allows us to 
accurately evaluate different mechanisms regulating 
microcirculation. In particular, data derived from human 
skin, reveal rhythmic oscillations in the frequency interval 
0.005-2.0 Hz. These fluctuations in blood flow have been 
demonstrated to be associated with several physiological 
factors, involved in the regulation of blood flow: the NO-
independent and NO-dependent endothelial activities, the 
sympathetic nervous system discharge, the intrinsic 
myogenic activity of vascular smooth muscle cells, the 
respiration and the heart rate [15-17]. 
Therefore, the aim of present study was to 
investigate the microvascular impairments in newly 
diagnosed hyperglycemic obese subjects using 
noninvasive LDPM technique. Skin microvascular blood 
flow (SBF) was evaluated under resting conditions in all 
recruited patients. Moreover, to assess peripheral 
microvascular reactivity, post-occlusive reactive 
hyperemia (PORH) was evaluated in a smaller group of 
patients. Oscillations in blood flow were analyzed by 
spectral analysis of LDPM signals to study the several 
factors modulating the blood distribution [18]. Finally, the 
effects of a low-glycemic and hypocaloric diet, 
administered for 6 months, were investigated in 
hyperglycemic subjects. This group was compared with an 
age-matched group of normoglycemic obese and an age-
matched group of normal weight subjects. 
 
II.  METHODS 
 
 Study groups. Fifty-four normoglycemic obese 
subjects (27 females, NG group); fifty-four newly 
diagnosed hyperglycemic obese patients (27 females, HG 
group) and fifty-four normal weight subjects (27 females, 
NW group) were recruited from the Outpatient Clinic of 
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the Department of Clinical Medicine and Surgery, 
“Federico II” University of Naples. In the HG group, 
hyperglycemia was diagnosed within 2 months before the 
study.  
All patients were 55-64 years old; those 
belonging to NG and HG groups were obese [body mass 
index (BMI) ≥ 30 Kg/m2], while those of NW group were 
normal weight (BMI between 19 - 25 Kg/m2). Exclusion 
criteria were: presence of disease influencing body 
composition (cancer, osteoporosis and muscular 
dystrophia), heart failure and microangiopathy; treatment 
with drug influencing microvascular blood flow (such as 
vasodilators and anti-inflammatory drugs), insulin or oral 
hypoglycemic drugs and smoking. 
The study was approved by “Federico II” 
University Institutional Ethical Committee; all patients 
gave their informed consent at recruitment. 
 
Dietary treatment. A hypocaloric diet (25 
kcal/kg body desirable weight), with 55-60 % of total 
caloric intake in carbohydrates, 10-15 % in proteins and 
25-30 % in fatty acids (< 7% saturated fats), was 
recommended to all obese patients. Carbohydrates were 
chosen according to their low glycemic index, while 
mono- and disaccharides were less than 7% of the total 
carbohydrate intake. NW group did not change the daily 
usual diet. 
 
Study protocol. Under baseline conditions (time 
T0), at 3 (time T1) and 6 (time T2) months of low-glycemic 
and hypocaloric diet administration, nutritional status, 
skin microvascular blood flow and blood flow oscillations 
were investigated. The NW group was studied at T0 and 
T2. 
Nutritional status was evaluated by 
anthropometric measurements: weight, body mass index 
(BMI), waist circumference (WC), hip circumference 
(HC) and triceps skinfold (TS). Bioimpedance analysis 
(Akern RJL, BIA 101) was carried out to evaluate Fat 
Mass (FM) and Fat Free Mass (FFM). Glycemia (Gly), 
glycated hemoglobin (HbA1c) and basal insulin were 
measured. Moreover, the insulin resistance was estimated 
by the homeostasis model assessment of insulin resistance 
(HOMA-IR). 
Microvascular blood flow evaluation was 
performed on the patients in supine position in a quiet and 
temperature-controlled room (22 ± 23 °C). No subjects 
had any medication, food, alcohol and/or drinks 
containing caffeine 12 h prior to the blood flow 
measurement. SBF was recorded using a laser Doppler 
perfusion monitoring apparatus (PeriFlux 4001 System, 
Perimed, Stockholm, Sweden) with the following 
characteristics: 780 nm wavelength, 10 Hz - 9 kHz 
bandwidth, 0.02 s time constant, 32 Hz sampling 
frequency. The LDPM apparatus was connected with a 
probe (PF 408, Perimed, Stockholm, Sweden), placed on 
the right forearm volar surface, and with a computer. After 
10 min of acclimatization period, digital blood flow was 
recorded for 20 min by a Perisoft software. The mean 
value of SBF was expressed as arbitrary perfusion units 
(PU), while the power spectral density (PSD) of laser 
Doppler signals was reported as PU2/Hz. Finally, skin 
blood flow oscillations were analyzed by Wavelet 
transform [18]. 
Post-occlusive reactive hyperemia was evaluated 
in 14 normoglycemic obese subjects (7 females), 16 
hyperglycemic obese patients (8 females) and 15 normal 
weight persons. After 20 min recording of microvascular 
blood flow under resting conditions, the brachial artery 
was occluded by a blood pressure cuff, placed at the right 
upper arm and inflated up to 50 mmHg above the systolic 
blood pressure. The blood pressure cuff was sudden 
deflated after 2 min brachial artery occlusion. Peak value 
(PK) was determined in PU as maximal perfusion value 
during hyperemia; percent increase of peak value (PK%) 
was calculated from the basal mean value; time to peak 
(Tp) was measured in seconds as the time from cuff 
release to the peak value; duration of hyperemia was 
evaluated in seconds as the time from cuff release up to 
the recovery of the mean value.  
All data were expressed as mean ± standard error 
of the mean (SEM). Data were tested for normal 
distribution with the Kolmogorov-Smirnov test. 
Parametric (Student’s t tests, ANOVA and Bonferroni 
post hoc test) or nonparametric tests (Wilcoxon, Mann-
Whitney and Kruskal-Wallis tests) were used. The 
statistical analysis was carried out by SPSS 14.0 statistical 
package. Statistical significance was set at p<0.05. 
 
Spectral analysis. Microvascular blood flow 
oscillations, in the range: 0.005 to 2.0 Hz, were evaluated 
by Wavelet transform, a scale dependent method 
comprising an adjustable window length able to analyze 
both low and high frequencies [18]. Spectral analysis was 
performed on 20 min recordings under resting conditions, 
to obtain higher resolution of very low frequency 
components. Wavelet analysis, proposed by Morlet, 
permits to detect at least six frequency components in this 
interval, as reported by Stefanovska et al [15, 16]. At first 
the overall spectral density of each frequency interval was 
determined; then the normalized spectral density for each 
frequency interval was evaluated as the ratio between the 
average spectral density of a specific frequency interval 
and the average total power spectral density. Therefore, 
the relative contribution of each frequency component was 
defined for the entire spectrum. 
 
III.  RESULTS 
 
The anthropometric measurements and the 
metabolic parameters of all recruited subjects are reported 
in Tables 1, 2 and 3. Under baseline conditions, all obese 
patients showed changes in the nutritional status with 
central obesity. In addition, hyperglycemic patients had 
significant higher levels of Hb1Ac, basal insulin and 
HOMA index compared to normoglycemic and normal 
weight ones. At 3 and 6 months of low-glycemic and 
hypocaloric diet, all obese patients showed a significant 
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reduction in BMI and anthropometric parameters, 
accompanied by an improvement in body composition: fat 
mass was significantly reduced in kilograms and in 
percentage, while percent fat free mass significantly 
increased. Furthermore, glycemia, Hb1Ac, basal insulin 
and HOMA index significantly improved in 






Table 1. Anthropometric measurements [body mass index (BMI), waist circumference (WC), hip circumference (HF) and triceps skinfold (TS)], body 
composition [Fat Mass (FM) and Fat Free Mass (FFM)] and metabolic parameters [Glycemia (Gly), glycated hemoglobin (HbA1c), basal insulin and 
HOMA index] under baseline conditions (T0), at three (T1) and six months (T2) of low-glycemic and hypocaloric diet in normoglycemic subjects (NG 
group). Data are reported as mean  SEM; *p<0.05 vs T0; **p<0.01 vs T0; °p<0.05 vs T1; °°p<0.01 vs T1. 
 
 NG GROUP 
FEMALES (n=27) MALES (n= 27) 
T0 T1 T2 T0 T1 T2 
BMI 34.7±0.8 32.9±0.9** 31.6±0.9** °° 34.0±1.1 32.0±1.1** 30.3±0.9** °° 
WC 105.2±2.1 101.8±2.1** 97.7±1.9** °° 112.9±2.5 108.4±2.5** 101.4±1.6** °° 
HC 114.3±1.6 111.9±1.6** 108.7±1.5** °° 111.6±2.5 107.0±2.7** 104.8±2.2** ° 
TS 28.7±1.4 26.3±1.2** 24.2±1.1** °° 25.4±1.5 22.6±1.6** 20.1±1.4** °° 
FM (Kg) 37.8±1.6 34.3±1.7** 31.7±1.5** °° 31.5±0.9 25.6±1.7** 21.9±1.5** °° 
FM (%) 43.5±1.2 41.3±1.4** 39.9±1.0** ° 31.4±0.9 26.9±0.9** 24.4±1.0** °° 
FFM (Kg) 48.6±1.1 47.7±0.9 47.0±0.7* 67.7±2.0 67.5±1.7 66.1±1.5* 
FFM (%) 56.5±1.2 58.7±1.4** 60.1±1.0** 68.6±0.9 73.1±0.9** 75.6±1.0** °° 
Glycemia 89.9±2.4 89.2±2.5 87.3±2.3* ° 93.3±1.7 92.8±1.8 90.7±1.9* 
Hb1Ac  5.5±0.9 5.3±0.5 5.3±0.2 5.7±1.0 5.5±1.3 5.2±0.6 
Basal insulin 11.2±2.3 9.5±1.4 8.8±1.5 10.9±2.0 9.7±1.5 9.1±1.6 




Table 2. Anthropometric measurements [body mass index (BMI), waist circumference (WC), hip circumference (HF) and triceps skinfold (TS)], body 
composition [Fat Mass (FM) and Fat Free Mass (FFM)] and metabolic parameters [Glycemia (Gly), glycated hemoglobin (HbA1c), basal insulin and 
HOMA index] under baseline conditions (T0), at three (T1) and six months (T2) of low-glycemic and hypocaloric diet in hyperglycemic patients (HG 
group). Data are reported as mean  SEM; *p<0.05 vs T0; **p<0.01 vs T0; °p<0.05 vs T1; °°p<0.01 vs T1. 
 
 HG GROUP 
FEMALES (n=27) MALES (n=27) 
T0 T1 T2 T0 T1 T2 
BMI 38.9±1.0 36.6±1.2** 35.4±1.1** °° 37.1±0.8 34.6±0.7** 33.3±0.7** °° 
WC 110.6±2.1 105.8±1.9** 103.8±1.8** °° 121.3±1.6 114.3±1.5** 110.3±1.6** °° 
HC 120.1±2.2 116.7±2.5** 115.2±2.3** °° 114.9±1.4 110.3±1.4** 109.6±1.6** ° 
TS 34.0±0.8 30.4±1.1** 28.9±1.0** °° 29.2±1.0 23.9±0.7** 22.5±0.8** 
FM (Kg) 42.9±2.1 39.4±1.7** 37.3±1.6** °° 34.8±1.8 30.9±0.9** 28.2±0.9** °° 
FM (%) 45.6±1.1 44.7±0.8 43.7±1.1** ° 31.6±1.0 30.4±0.4 28.9±0.5** °° 
FFM (Kg) 50.1±1.4 47.9±1.4** 47.3±1.4** 73.6±1.2 70.0±1.4** 69.0±1.5** ° 
FFM (%) 54.4±1.1 55.2±0.8** 56.3±1.1** °° 68.4±1.0 69.6±0.4 71.1±0.5** °° 
Glycemia 121.8±3.2 102.2±1.7** 100.1±1.7** °° 139.5±6.8 115.0±3.5** 104.4±2.2** °° 
Hb1Ac 7.7±0.5 6.0±0.1** 5.4±0.5 7.1±0.8 5.9±0.1** 5.7±0.1** 
Basal insulin 15.1±1.5 11.6±1.9** 9.6±2.1°° 15.1±1.2 11.5±1.8** 10.7±1.6** 
HOMA index 4.5±0.4 2.8±0.3** 2.2±0.3** 5.2±0.4 3.1±0.3** 2.6±0.3** 
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Table 3. Anthropometric measurements [body mass index (BMI), waist circumference (WC), hip circumference (HF) and triceps skinfold (TS)], body 
composition [Fat Mass (FM) and Fat Free Mass (FFM)] and metabolic parameters [Glycemia (Gly), glycated hemoglobin (HbA1c), basal insulin and 
HOMA index] under baseline conditions (T0) and after six months (T2) of daily usual diet in normal weigh patients (NW group). Data are reported as 




SBF evaluation under resting conditions. 
LDPM measurements revealed significant differences 
between normoglycemic and hyperglycemic obese 
patients under baseline conditions (time T0) compared to 
normal weight subjects. Hyperglycemic subjects showed 
lower mean value of SBF than normoglycemic ones (9.9 ± 
0.5 vs 11.8 ± 0.6 PU, p<0.01 vs NG group; Figure 1), 
while normal weight subjects had baseline perfusion of 
11.3 ± 0.5 PU (p<0.01 vs HG group). Moreover, spectral 
analysis indicates that total PSD of SBF recording was 
lower in the hyperglycemic than in normoglycemic obese 
and normal weight subjects (113.2 ± 10.1 vs 176.5 ± 11.4 
and 170.4 ± 12.3 PU2/Hz, p<0.01 vs NG and NW group). 
Under baseline conditions, in all LDPM tracings, 
several frequency components were detected; four in low 
frequency component ranges: 0.005-0.0095 Hz, 0.0095-
0.021 Hz, 0.021-0.052 Hz and 0.052-0.15 Hz. These 
frequency components were related to the NO-
independent and NO-dependent endothelium activity, 
neurogenic and myogenic activities, respectively. Other 
two high frequency components were detected in the 
ranges: 0.15-0.6 Hz and 0.6-2.0 Hz, related to the 
respiratory and heart rates, respectively. The power 
spectral density of neurogenic and myogenic activities 
were higher than those related to the other parameters, as 
observed in normal weight subjects (Figure 2). However, 
in hyperglycemic patients the PSD related to myogenic 
activity (in percentage of total spectral density) was 
significantly lower than in normoglycemic obese and 
normal weight subjects (30.1 ± 0.7 vs 34.9 ± 0.7 and 38.3 
± 0.6 %, p<0.01 vs NG and NW groups; Figure 2). On the 
other hand, percent NO-dependent spectral density was 
higher (10.3 ± 0.7 vs 7.9 ± 0.3 %, p<0.01 vs NG) in 
hyperglycemic than in normoglycemic obese patients, but 
there was no significant difference when compared with 
the values evaluated in normal weight subjects  (9.8 ± 1.0 
%; Figure 2). The changes in the low frequency 
component spectral density were accompanied by the 
corresponding variations in high frequency components: 
respiration-related spectral density was higher in 
hyperglycemic than in normoglycemic and normal weight 
persons (16.5 ± 0.8 vs 10.1 ± 0.6 and 9.7 ± 0.5 %, p<0.01 
vs NG and NW groups), while hearth rate related spectral 
density was the lowest in normal weight subjects (3.1 ± 
0.2 vs 10.5 ± 1.0 and 6.8 ± 0.4 %, p<0.01 vs NG and HG 
groups) (Figure 2). 
At 6 months of dietary treatment (time T2), SBF 
(Figure 1) and total PSD of LDPM oscillations 
significantly increased in hyperglycemic patients. In 
particular, at 6 months of a low-glycemic and hypocaloric 
diet administration, SBF was 12.3 ± 0.4 PU (p<0.01 vs T0; 
Figure 1), while total PSD of LDPM signals was 323.3 ± 
10.1 PU2/Hz (p<0.01 vs T0). Furthermore, spectral 
analysis revealed a significant increase in myogenic 
related component (35.4 ± 1.5 vs 30.1 ± 0.7 %, p<0.01 vs 
T0), while NO-dependent endothelial-related component 
showed a trend to decrease (9.4 ± 0.9 vs 10.3 ± 0.7) 
(Figure 3). Finally, high frequency components showed a 
decrease for the respiration and an increase for heart rate-
related components, compared to T0 values (p<0.01). In 
normal weight subjects, we did not detect any significant 
parameter change, at 6 months of observation (Figure 3). 
 NW GROUP 
FEMALES (n=27) FEMALES (n=27) MALES (n=27) MALES (n=27) 
 T0 T2 T0 T2 
BMI 23.6±1.0 23.8±1.3 24.5±0.6 25.1±1.3 
WC 83.0±1.6 83.4±1.0 92.6±1.8 92.3±2.0 
HC 98.4±1.1 98.1±0.5 95.8±1.5 96.0±1.8 
TS 17.3±2.2 17.5±1.5 14.3±1.7 14.5±1.5 
FM (Kg) 20.2±1.3 20.5±2.0 16.3±1.3 16.5±1.8 
FM (%) 31.4±1.5 31.5±1.8 22.5±1.6 22.7±1.3 
FFM (Kg) 44.4±2.1 44.5±2.1 55.8±1.4 55.9±2.1 
FFM (%) 68.5±1.3 68.7±0.6 77.5±1.6 77.7±2.3 
Glycemia 88±1.6 86.5±2.2 91.3±1.7 91.0±1.5 
Hb1Ac 5.2±0.5 5.0±0.8 5.1±0.8 4.9±0.5 
Basal insulin 8.7±1.4 7.7±1.0 9.2±0.9 9.7±1.0 
HOMA index 1.8±0.4 1.7±0.3 2.1±0.4 2.2±0.6 
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Figure 1. Skin microvascular blood flow, expressed as Perfusion Units 
(PU), under baseline conditions (T0) and at six months (T2) of diet 
administration in normal weight (NW), normoglycemic (NG) and 
hyperglycemic patients (HG). ° p<0.01 vs T0 NW group, * p<0.01 vs T0 
NG group ; ** p< 0.01 vs T0 
 
Figure 2. Normalized power spectral density, expressed as percent, 
related to NO-independent endothelial activity (1), NO-dependent 
endothelial activity (2), neurogenic activity (3), myogenic activity (4), 
respiration (5) and heart rate (6) under baseline conditions (T0) in normal 
weight (NW), normoglycemic (NG) and hyperglycemic patients (HG). ° 
p< 0.01 vs T0 NW group, * p< 0.01 vs T0 NG group. 
 
Figure 3. Normalized power spectral density, expressed as percent, 
related to NO-independent endothelial activity (1), NO-dependent 
endothelial activity (2), neurogenic activity (3), myogenic activity (4), 
respiration (5) and heart rate (6), at six months (T2) of diet administration 
in normal weight (NW), normoglycemic (NG) and hyperglycemic 
patients (HG). ° p< 0.01 vs T2 NW group, * p< 0.01 vs T2 NG group. 
SBF evaluation during PORH. Hyperemic 
response was significantly different in the experimental 
groups under baseline conditions (time T0), resulting 
impaired in hyperglycemic group. In particular, all groups 
showed an increase in microvascular blood flow above the 
baseline following 2 min brachial artery occlusion. 
However, the peak value was lower in hyperglycemic than 
in normoglycemic and normal weight subjects (30.8 ± 2.9 
vs 60.3 ± 2.5 and 72.3 ± 1.5 PU, respectively; p<0.01 vs 
NG and NW groups; Figure 4)  as well as the percent 
increase from baseline (345.3 ± 28.0 vs 552.0 ± 27.4 and 
670.0 ± 15.6 %, respectively;  p<0.01 vs NG and NW 
groups) and the duration of hyperemia (30.1 ± 1.2 vs 41.9 
± 2.2 and 43.2 ± 1.3 seconds, p<0.01 vs NG and NW 
groups). Consequently, time to peak was higher in 
hyperglycemic than in normoglycemic and normal weight 
subjects (9.2 ± 0.5 vs 7.1 ± 0.3 and 5.9 ± 0.2 seconds, 
respectively; p<0.01 vs NG and NW groups; Figure 5). 
At 3 and 6 months of dietary treatment (time T1 
and time T2, respectively), a significant recovery in 
hyperemic response was detected in hyperglycemic 
subjects. At 6 months of treatment, indeed, the peak value 
significantly increased (68.0 ± 2.1 vs 30.8 ± 2.9 PU, 
p<0.01 vs T0; Figure 4) as well as the percent increase 
from baseline (729.4 ± 24.9 vs 345.3 ± 28.0, p<0.01 vs T0) 
and the duration of hyperemia (36.4 ± 0.8 vs 30.1 ± 1.2 
seconds, p<0.01 vs T0). On the other hand, time to peak 
was significantly reduced in these hyperglycemic patients 
(6.0 ± 0.5 vs 9.2 ± 0.5 seconds, p<0.01 vs T0; Figure 5). 
 
Figure 4. Peak value, expressed as Perfusion Units (PU), under baseline 
conditions (T0) and at six months (T2) of diet administration in normal 
weight (NW), normoglycemic (NG) and hyperglycemic patients (HG). 
° p< 0.01 vs T0 NW group , * p< 0.01 vs T0 NG group, ** p<0.01 vs T0. 
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Figure 5. Time to peak, expressed in seconds, under baseline conditions 
(T0) and at six months (T2) of diet administration in normal weight 
(NW), normoglycemic (NG) and hyperglycemic patients (HG). 




 The present results indicate that obesity, in adult 
patients, is characterized by changes in peripheral 
microcirculation, under resting conditions as well as 
during post-occlusive reactive hyperemia (PORH). It is 
well known that skin microvascular blood flow presents 
several oscillations due to the different mechanisms 
regulating the blood flow distribution. Spectral density 
analysis allowed us to identify the frequency components 
of these oscillations in the range: 0.005-2.0 Hz. According 
to previous findings, these frequency components may be 
related to six different physiological mechanisms [15-17]. 
Our data show that the sympathetic nervous system 
discharge and activity of smooth muscle cells are mainly 
involved in the regulation of microvascular blood flow 
distribution. However, a significant reduction in the 
myogenic activity and in NO-independent endothelial 
activity was observed in the obese subjects, compared to 
normal weight persons. These changes in the oscillatory 
patterns were accompanied by a compensatory 
modification of the high frequency component related to 
the central drive from the heart, significantly increased in 
the obese subjects. These data indicate that obesity could 
be mainly associated to a reduced myogenic activity of 
arterioles, as previously reported [19]. Moreover, our data 
indicate that obesity-associated hyperglycaemia represents 
an additional factor able to exacerbate microvascular 
impairment. In hyperglycaemic obese patients, indeed, 
SBF and total power spectral density of skin 
microvascular blood flow oscillations appeared to be 
lower than in normoglycemic obese subjects. This finding 
suggests an increase in peripheral resistance and, 
consequently, changes in microvascular regulatory 
mechanisms. Moreover, the myogenic related component 
appeared significantly reduced, compared to the same 
component evaluated in normoglycemic obese subjects. 
These changes were accompanied by a modification of the 
high frequency component  related to respiration, higher 
in hyperglycemic obese, compared to normoglycemic 
obese persons. It is worth noting that NO-dependent 
frequency component, in hyperglycemic obese patients, 
was not significantly different compared to the same 
component in normal weight subjects, but higher than in 
normoglycemic obese persons. Therefore, obesity appears 
to be characterized by a significant decrease in NO-
independent endothelium activity, with a trend to increase 
in NO-dependent component. Therefore, it is reasonable 
to hypothesize that hyperglycaemia-induced oxidative 
stress markedly affects smooth muscle cells, impairing 
their contractile/relaxation function and increasing 
peripheral resistance, as indicated by the decrease in NO-
independent endothelium activity and further decrease in 
myogenic activity, with concomitant increase in 
respiration-related activity [20]. These data are in 
agreement with previous results, demonstrating severe 
smooth muscle dysfunction in type II diabetes mellitus 
[21, 22].  
To investigate the responses of skin 
microcirculation, we used LDPM in combination with 
post-occlusive reactive hyperaemia (PORH) test. 
Hyperemic response appeared slight attenuated in obese 
patients, compared to normal weight persons, and 
particularly lower in hyperglycaemic obese, compared to 
normoglycemic obese persons. These data confirm that 
obesity-associated hyperglycaemia significantly affects 
microvascular function, under resting conditions as well 
as after acute hyperaemic response. Since many mediators 
contribute to the post-occlusive hyperemia, such as axon 
reflex, different local mediators and vascular smooth 
muscle cell activity, it is possible to hypothesize that 
PORH can be related to the overall functions localized in 
the arteriolar vessel walls [14, 24]. 
Our results, however, demonstrated that the 
recovery in nutritional status and the significant reduction 
in bioumoral parameters, including glycemia, Hb1Ac, 
basal insulin and HOMA index, were accompanied by an 
improvement in blood flow oscillations. In particular, the 
low-glycemic and hypocaloric diet determined a 
significant increase in SBF and total power spectral 
density in hyperglycemic obese patients. Similarly, 
spectral analysis revealed an increase in myogenic 
activity, indicating an improvement in vascular smooth 
muscle activity. Accordingly, the high frequency 
components were differently affected, decreasing the 
respiration- and increasing the heart rate- related 
components.  Finally, the recovery of smooth muscle cell 
functions was confirmed by the improvement in the 
hyperaemic response, observed in these patients. 
 In conclusion, our data demonstrate that obese 
subjects have microvascular impairment, exacerbated by 
hyperglycaemia, mainly inducing a severe disfunction in 
smooth muscle cell activity with alterations of post-
occlusive hyperaemic responses. Therefore, a low-
glycemic and hypocaloric diet could promote a recovery 
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